Aptinyx Inc | APTX - Cash And Equivalent

Aptinyx Inc reported $66.58M in Cash and Equivalent for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Cash And Equivalent Change
Acadia Pharmaceuticals ACAD:US USD 114.85M 40M
Acorda Therapeutics ACOR:US USD 37.54M 16.84M
Biogen BIIB:US USD 3.42B 256.3M
Cara Therapeutics CARA:US USD 63.74M 20.94M
Daiichi Sankyo 4568:JP JPY 395.18B 85.04B
Halozyme Therapeutics HALO:US USD 234.2M 87.04M
Intra Cellular Therapies ITCI:US USD 148.61M 13.26M
IONIS PHARMACEUT IONS:US USD 276.47M 38.52M
Marinus Pharmaceuticals MRNS:US USD 240.55M 72.3M
Neurocrine Biosciences NBIX:US USD 262.9M 50.7M
Novartis NOVN:VX USD 7.52B 1.21B
Ultragenyx Pharmaceutical RARE:US USD 132.94M 258.71M
Vertex Pharmaceuticals VRTX:US USD 10.78B 1.61B